Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Applied Optics|March 10, 2018
Method to measure 3D deformation using defocused images of objects with artificial speckle featuresJiong Qian, Qin-Zhi Fang, Qinwei Hu, et al.Applied Optics|March 2, 2017
Optical method to measure the surface of objects by using only one photoQin-Zhi Fang, Jiong Qian, HyeonGyu Beom, et al.Oncotarget|October 4, 2017
LncRNA UCA1 in anti-cancer drug resistanceHaohao Wang, Zhonghai Guan, Kuifeng He, et al.World Journal of Clinical Cases|September 26, 2022
Long-term survival of gastric mixed neuroendocrine-non-neuroendocrine neoplasm: Two case reportsLun-Tao Woo, Yong-Feng Ding, Chen-Yu Mao, et al.Medicine|May 18, 2019
A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in ChinaCheng Xiao, Jiong Qian, Yulong Zheng, et al.American Journal of Translational Research|December 19, 2025
Synergistic antitumor efficacy of CIK cells combined with PD-1 inhibitors in nasopharyngeal carcinomaJing Chen, Tumaer Sailihan, Yanhong Chen, et al.BMC Cancer|June 15, 2007
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumNong Xu, Xiao Chen Zhang, Jian Ping Xiong, et al.American Journal of Cancer Research|March 9, 2022
Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in advanced esophageal squamous cell carcinomaWu Lin, Jiong Qian, Haohao Wang, et al.Current Oncology (Toronto, Ont.)|November 24, 2022
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with ChemotherapyXiaolu Ma, Yongfeng Ding, Jiong Qian, et al.Cancer Medicine|October 3, 2023
The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancerMingyu Wan, Yongfeng Ding, Xiaolu Ma, et al.Pageof 2